# Autism Biomarker Consortium for Clinical Trials

> **NCT02996669** · — · COMPLETED · sponsor: **Yale University** · enrollment: 399 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02996669
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-05-13
- **Final completion:** 2019-05-13
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2020-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02996669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02996669, "Autism Biomarker Consortium for Clinical Trials". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02996669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*